Changeflow GovPing Pharma & Drug Safety EPO Grants Patent for Antigen-Presenting Cell-M...
Routine Notice Added Final

EPO Grants Patent for Antigen-Presenting Cell-Mimetic Scaffolds

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office (EPO) has granted patent EP3484448B1 for antigen-presenting cell-mimetic scaffolds and methods for their creation and use. The patent was published on March 18, 2026, and lists Alexander Sing Cheung and David J. Mooney as inventors.

What changed

The European Patent Office (EPO) has granted patent EP3484448B1, titled 'ANTIGEN-PRESENTING CELL-MIMETIC SCAFFOLDS AND METHODS FOR MAKING AND USING THE SAME'. The patent, designated with kind code B1, was published on March 18, 2026, and lists inventors Alexander Sing Cheung and David J. Mooney. The International Patent Classification (IPC) includes codes related to cell culture, drug delivery systems, and therapeutic uses, particularly in oncology.

This grant signifies the official recognition of intellectual property rights for the described technology within the designated European states. While this is a patent grant and not a regulatory rule, it impacts the landscape for companies involved in biotechnology and pharmaceutical research and development, particularly those working on immunotherapies or cell-based treatments. Companies operating in this space should be aware of this granted patent to ensure their own research and commercial activities do not infringe upon the patent holder's exclusive rights.

Source document (simplified)

← EPO Patent Bulletin

ANTIGEN-PRESENTING CELL-MIMETIC SCAFFOLDS AND METHODS FOR MAKING AND USING THE SAME

Grant EP3484448B1 Kind: B1 Mar 18, 2026

Inventors

CHEUNG, Alexander, Sing, MOONEY, David, J.

IPC Classifications

C12N 5/00 20060101AFI20240926BHEP A61K 9/127 20250101ALI20240926BHEP A61P 35/00 20060101ALI20240926BHEP B82Y 5/00 20110101ALI20240926BHEP C12N 5/0783 20100101ALI20240926BHEP A61K 39/00 20060101ALN20240926BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

ANTIGEN-PRESENTING CELL-MIMETIC SCAFFOLDS AND METHODS FOR MAKING AND USING THE SAME

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3484448B1

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Biotechnology Research
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Biotechnology Medical Devices

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.